Arrowhead Research ( ARWR) Company Profile: Arrowhead Research is a development stage nanotechnology holding company that forms, acquires and operates subsidiaries commercializing innovative nanotechnologies. Current Share Price: 99 cents (Jan. 3) 2010 Stock Performance: 69% Received Nasdaq Notice: Dec. 8 Management's Expected Action: Arrowhead said in a regulatory filing that it has until June 6, 2011, to regain compliance with the minimum closing bid price requirement for continued listing. However, the company did not outline any plans to cure the deficiency. Arrowhead has previously been faced with a possible delisting for non-compliance with the Nasdaq's listing requirements. In March, Arrowhead was granted an additional 180-day grace period to regain compliance with the bid price rule before managing to satisfy the requirement in April.